Highlights Intellipharmaceutics International Inc.

Equities

IPCI.H

CA4581733090

Delayed Toronto S.E. Other stock markets 09:30:00 21/03/2024 pm IST			5-day change	1st Jan Change
0.08 ^CAD	-.--%		-11.11%	+6.67%

03/01	IntelliPharmaCeutics International Receives Conditional Approval For TSXV Listing	MT
2023	Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IntelliPharmaCeutics International Receives Conditional Approval For TSXV Listing	03/01	MT
Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	17/23/17	CI
Intellipharmaceutics International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	15/23/15	CI
IntelliPharmaCeutics International Fiscal Q2 Loss Narrows on Higher Revenue	15/23/15	MT
Intellipharmaceutics International Narrows Fiscal Q1 Loss, Revenue Rises	06/23/06	MT
Intellipharmaceutics International Inc. Brief: Recorded net loss for Q1 of US$355,738 or $0.01 per common shar	06/23/06	MT
Intellipharmaceutics International Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023	05/23/05	CI
Ontario Securities Commission Denies Intellipharmaceutics' Application for Management Cease Trade Order	08/23/08	MT
Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	15/22/15	CI
Intellipharmaceutics International Fiscal Q3 Loss Widens	15/22/15	MT
Intellipharmaceutics International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	22/22/22	CI
Intellipharmaceutics International Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022	15/22/15	CI
IntelliPharmaCeutics International Fiscal Q1 Loss Narrows	15/22/15	MT
Earnings Flash (IPCIF) INTELLIPHARMACEUTICS INTERNATIONAL Reports Q1 Loss $-0.03	15/22/15	MT
Intellipharmaceutics International Inc. Reports Earnings Results for the Full Year Ended November 30, 2021	28/22/28	CI
Intellipharmaceutics International Inc. Reports Earnings Results for the Third Quarter Ended August 31, 2021	16/21/16	CI
Intellipharmaceutics International Inc. Reports Earnings Results for the Second Quarter Ended May 31, 2021	15/21/15	CI
Intellipharmaceutics International : Details Q1 2021 Results	14/21/14	MT
Intellipharmaceutics International Inc. Reports Earnings Results for the First Quarter Ended February 28, 2021	14/21/14	CI
Intellipharmaceutics International Inc. Reports Earnings Results for the Full Year Ended November 30, 2020	01/21/01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Intellipharmaceutics International Inc.

Equities

IPCI.H

CA4581733090

Highlights

Filters